1-6 of 6
tumor microenvironment
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Alex Reza Gholiha, Peter Hollander, Ingrid Glimelius, Gustaf Hedstrom, Daniel Molin, Henrik Hjalgrim, Karin E. Smedby, Jamileh Hashemi, Rose-Marie Amini, Gunilla Enblad
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1671–1681.
https://doi.org/10.1182/bloodadvances.2020003664
Published: 2021
Includes: Supplemental data
Journal Articles

Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas

Alexander Neuwelt, Taha Al-Juhaishi, Eduardo Davila, Bradley Haverkos
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4256–4266.
https://doi.org/10.1182/bloodadvances.2020001966
Published: 2020
Journal Articles

Gene expression profiling of gray zone lymphoma

Clémentine Sarkozy, Lauren Chong, Katsuyoshi Takata, Elizabeth A. Chavez, Tomoko Miyata-Takata, Gerben Duns, Adèle Telenius, Merrill Boyle, Graham W. Slack, Camille Laurent, Pedro Farinha, Thierry J. Molina, Christiane Copie-Bergman, Diane Damotte, Gilles A. Salles, Anja Mottok, Kerry J. Savage, David W. Scott, Alexandra Traverse-Glehen, Christian Steidl
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2523–2535.
https://doi.org/10.1182/bloodadvances.2020001923
Published: 2020
Includes: Supplemental data
Journal Articles

Tumor microenvironment and clonal monocytes from chronic myelomonocytic leukemia induce a procoagulant climate

Johanna Zannoni, Natacha Mauz, Landry Seyve, Mathieu Meunier, Karin Pernet-Gallay, Julie Brault, Claire Jouzier, David Laurin, Mylène Pezet, Martine Pernollet, Jean-Yves Cahn, Fabrice Cognasse, Benoît Polack, Sophie Park
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1868–1880.
https://doi.org/10.1182/bloodadvances.2018026955
Published: 2019
Includes: Supplemental data
Journal Articles

Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model

Chandini M. Thirukkumaran, Zhong Qiao Shi, Gerard J. Nuovo, Joanne Luider, Karen A. Kopciuk, Yuan Dong, Ahmed A. Mostafa, Satbir Thakur, Kathy Gratton, Ailian Yang, Alex C. Chin, Matt C. Coffey, Victor H. Jimenez-Zepeda, Douglas Stewart, Marta Chesi, P. Leif Bergsagel, Don Morris
Journal: Blood Advances
Blood Adv (2019) 3 (5): 797–812.
https://doi.org/10.1182/bloodadvances.2018025593
Published: 2019
Includes: Supplemental data
Journal Articles

Patient-derived xenografts of low-grade B-cell lymphomas demonstrate roles of the tumor microenvironment

W. Richard Burack, Janice M. Spence, John P. Spence, Stephen A. Spence, Philip J. Rock, Gautam N. Shenoy, Leonard D. Shultz, Richard B. Bankert, Steven H. Bernstein
Journal: Blood Advances
Blood Adv (2017) 1 (16): 1263–1273.
https://doi.org/10.1182/bloodadvances.2017005892
Published: 2017
Includes: Supplemental data